Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study

British Journal of Haematology

Volumn 169, Issue 3, 2015, Pages 356-367

  Suehiro, Youko ^a   Hasegawa, Atsuhiko ^b   Iino, Tadafumi ^c   Sasada, Amane ^b   Watanabe, Nobukazu ^d   Matsuoka, Masao ^e   Takamori, Ayako ^b   Tanosaki, Ryuji ^f   Utsunomiya, Atae ^g   Choi, Ilseung ^a   Fukuda, Tetsuya ^b   Miura, Osamu ^b   Takaishi, Shigeo ^c   Teshima, Takanori ^h   Akashi, Koichi ^c   Kannagi, Mari ^b   Uike, Naokuni ^a   Okamura, Jun ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g Imamura Bun in Hospital   (Japan)

^h HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adult T cell leukaemia lymphoma; Cytotoxic T lymphocyte; Dendritic cell; Human T cell leukaemia virus type I; Tumour vaccine

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CHEMOKINE RECEPTOR CCR4; DENDRITIC CELL VACCINE; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 2 RECEPTOR; LENALIDOMIDE; MOGAMULIZUMAB; PREDNISONE; SOBUZOXANE; TAX PEPTIDE PULSED DENDRITIC CELL VACCINE; TAX PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE; CANCER VACCINE; CYTOKINE; PEPTIDE FRAGMENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LOW DRUG DOSE; LYMPHADENOPATHY; MALE; MONOCYTE; NONALCOHOLIC FATTY LIVER; PHENOTYPE; PILOT STUDY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SPLENOMEGALY; T CELL LEUKEMIA; T CELL LYMPHOMA; THROMBOCYTOPENIA; TUMOR CELL; VACCINATION; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DENDRITIC CELL; GENETICS; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOLOGY; IMMUNOTHERAPY; LEUKEMIA-LYMPHOMA, ADULT T-CELL; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER VACCINES; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOTHERAPY; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PILOT PROJECTS; T-LYMPHOCYTES, CYTOTOXIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84927694937     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13302     Document Type: Article

References (37)

1. De Keersmaecker, B., Allard, S.D., Lacor, P., Schots, R., Thielemans, K. & Aerts, J.L. (2012) Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs. Journal of Virology, 86, 9351-9360.
2. Fuessel, S., Meye, A., Schmitz, M., Zastrow, S., Linne, C., Richter, K., Lobel, B., Hakenberg, O.W., Hoelig, K., Rieber, E.P. & Wirth, M.P. (2006) Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial. The Prostate, 66, 811-821.
3. Gill, P.S., Harrington, W. Jr, Kaplan, M.H., Ribeiro, R.C., Bennett, J.M., Liebman, H.A., Bernstein-Singer, M., Espina, B.M., Cabral, L., Allen, S., Kornblau, M.D., Pike, M.C. & Levine, A.M. (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine, 332, 1744-1748.
4. Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Hasegawa, A., Takemura, F., Masuda, T. & Kannagi, M. (2001) Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity. Journal of the National Cancer Institute, 93, 1775-1783.
5. Harashima, N., Kurihara, K., Utsunomiya, A., Tanosaki, R., Hanabuchi, S., Masuda, M., Ohashi, T., Fukui, F., Hasegawa, A., Masuda, T., Takaue, Y., Okamura, J. & Kannagi, M. (2004) Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Research, 64, 391-399.
6. Harashima, N., Tanosaki, R., Shimizu, Y., Kurihara, K., Masuda, T., Okamura, J. & Kannagi, M. (2005) Identification of two new HLA-A * 1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. Journal of Virology, 79, 10088-10092.
7. Hermine, O., Bouscary, D., Gessain, A., Turlure, P., Leblond, V., Franck, N., Buzyn-Veil, A., Rio, B., Macintyre, E., Dreyfus, F. & Bazarbachi, A. (1995) Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. New England Journal of Medicine, 332, 1749-1751.
8. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K.I., Shirakawa, S. & Miyoshi, I. (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proceedings of the National Academy of Sciences of the United States of America, 78, 6476-6480.
9. Hishizawa, M., Imada, K., Kitawaki, T., Ueda, M., Kadowaki, N. & Uchiyama, T. (2004) Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. British Journal of Haematology, 125, 568-575.
10. Hishizawa, M., Kanda, J., Utsunomiya, A., Taniguchi, S., Eto, T., Moriuchi, Y., Tanosaki, R., Kawano, F., Miyazaki, Y., Masuda, M., Nagafuji, K., Hara, M., Takanashi, M., Kai, S., Atsuta, Y., Suzuki, R., Kawase, T., Matsuo, K., Nagamura-Inoue, T., Kato, S., Sakamaki, H., Morishima, Y., Okamura, J., Ichinohe, T. & Uchiyama, T. (2010) Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood, 116, 1369-1376.
11. Ishida, T. & Ueda, R. (2011) Immunopathogenesis of lymphoma: focus on CCR4. Cancer Science, 102, 44-50.
12. Ishida, T., Joh, T., Uike, N., Yamamoto, K., Utsunomiya, A., Yoshida, S., Saburi, Y., Miyamoto, T., Takemoto, S., Suzushima, H., Tsukasaki, K., Nosaka, K., Fujiwara, H., Ishitsuka, K., Inagaki, H., Ogura, M., Akinaga, S., Tomonaga, M., Tobinai, K. & Ueda, R. (2012) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. Journal of Clinical Oncology, 30, 837-842.
13. Ishida, T., Hishizawa, M., Kato, K., Tanosaki, R., Fukuda, T., Takatsuka, Y., Eto, T., Miyazaki, Y., Hidaka, M., Uike, N., Miyamoto, T., Tsudo, M., Sakamaki, H., Morishima, Y., Suzuki, R. & Utsunomiya, A. (2013) Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study. Biology of Blood and Marrow Transplantation, 19, 1731-1739.
14. Jacobson, S., Shida, H., McFarlin, D.E., Fauci, A.S. & Koenig, S. (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature, 348, 245-248.
15. Jones, K.S., Petrow-Sadowski, C., Huang, Y.K., Bertolette, D.C. & Ruscetti, F.W. (2008) Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nature Medicine, 14, 429-436.
16. Kannagi, M., Shida, H., Igarashi, H., Kuruma, K., Murai, H., Aono, Y., Maruyama, I., Osame, M., Hattori, T., Inoko, H. & Harada, S. (1992) Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. Journal of Virology, 66, 2928-2933.
17. Katsuya, H., Yamanaka, T., Ishitsuka, K., Utsunomiya, A., Sasaki, H., Hanada, S., Eto, T., Moriuchi, Y., Saburi, Y., Miyahara, M., Sueoka, E., Uike, N., Yoshida, S., Yamashita, K., Tsukasaki, K., Suzushima, H., Ohno, Y., Matsuoka, H., Jo, T., Suzumiya, J. & Tamura, K. (2012) Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. Journal of Clinical Oncology, 30, 1635-1640.
18. Kurihara, K., Harashima, N., Hanabuchi, S., Masuda, M., Utsunomiya, A., Tanosaki, R., Tomonaga, M., Ohashi, T., Hasegawa, A., Masuda, T., Okamura, J., Tanaka, Y. & Kannagi, M. (2005) Potential immunogenicity of adult T cell leukemia cells in vivo. International Journal of Cancer, 114, 257-267.
19. Lee, B., Tanaka, Y. & Tozawa, H. (1989) Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. The Tohoku Journal of Experimental Medicine, 157, 1-11.
20. Linette, G.P., Zhang, D., Hodi, F.S., Jonasch, E.P., Longerich, S., Stowell, C.P., Webb, I.J., Daley, H., Soiffer, R.J., Cheung, A.M., Eapen, S.G., Fee, S.V., Rubin, K.M., Sober, A.J. & Haluska, F.G. (2005) Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity. Clinical Cancer Research, 11, 7692-7699.
21. Makino, M., Wakamatsu, S., Shimokubo, S., Arima, N. & Baba, M. (2000) Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. Virology, 274, 140-148.
22. Nagayama, H., Sato, K., Morishita, M., Uchimaru, K., Oyaizu, N., Inazawa, T., Yamasaki, T., Enomoto, M., Nakaoka, T., Nakamura, T., Maekawa, T., Yamamoto, A., Shimada, S., Saida, T., Kawakami, Y., Asano, S., Tani, K., Takahashi, T.A. & Yamashita, N. (2003) Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. Melanoma Research, 13, 521-530.
23. Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T. & Kannagi, M. (2000) Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine. Journal of Virology, 74, 9610-9616.
24. Okamura, J., Utsunomiya, A., Tanosaki, R., Uike, N., Sonoda, S., Kannagi, M., Tomonaga, M., Harada, M., Kimura, N., Masuda, M., Kawano, F., Yufu, Y., Hattori, H., Kikuchi, H. & Saburi, Y. (2005) Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood, 105, 4143-4145.
25. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D. & Gallo, R.C. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 77, 7415-7419.
26. Rende, F., Cavallari, I., Corradin, A., Silic-Benussi, M., Toulza, F., Toffolo, G.M., Tanaka, Y., Jacobson, S., Taylor, G.P., D'Agostino, D.M., Bangham, C.R. & Ciminale, V. (2011) Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood, 117, 4855-4859.
27. Takamori, A., Hasegawa, A., Utsunomiya, A., Maeda, Y., Yamano, Y., Masuda, M., Shimizu, Y., Tamai, Y., Sasada, A., Zeng, N., Choi, I., Uike, N., Okamura, J., Watanabe, T., Masuda, T. & Kannagi, M. (2011) Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology, 8, 100.
28. Takeda, S., Maeda, M., Morikawa, S., Taniguchi, Y., Yasunaga, J., Nosaka, K., Tanaka, Y. & Matsuoka, M. (2004) Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. International Journal of Cancer, 109, 559-567.
29. Tanosaki, R., Uike, N., Utsunomiya, A., Saburi, Y., Masuda, M., Tomonaga, M., Eto, T., Hidaka, M., Harada, M., Choi, I., Yamanaka, T., Kannagi, M., Matsuoka, M. & Okamura, J. (2008) Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biology of Blood and Marrow Transplantation, 14, 702-708.
30. Thomas-Kaskel, A.K., Zeiser, R., Jochim, R., Robbel, C., Schultze-Seemann, W., Waller, C.F. & Veelken, H. (2006) Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival. International Journal of Cancer, 119, 2428-2434.
31. Tsukasaki, K., Hermine, O., Bazarbachi, A., Ratner, L., Ramos, J.C., Harrington, W. Jr, O'Mahony, D., Janik, J.E., Bittencourt, A.L., Taylor, G.P., Yamaguchi, K., Utsunomiya, A., Tobinai, K. & Watanabe, T. (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. Journal of Clinical Oncology, 27, 453-459.
32. Tsukasaki, K., Tobinai, K., Hotta, T. & Shimoyama, M. (2012) Lymphoma study group of JCOG. Japanese Journal of Clinical Oncology, 42, 85-95.
33. Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. & Uchino, H. (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood, 50, 481-492.
34. Ueda, Y., Itoh, T., Nukaya, I., Kawashima, I., Okugawa, K., Yano, Y., Yamamoto, Y., Naitoh, K., Shimizu, K., Imura, K., Fuji, N., Fujiwara, H., Ochiai, T., Itoi, H., Sonoyama, T., Hagiwara, A., Takesako, K. & Yamagishi, H. (2004) Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas. International Journal of Oncology, 24, 909-917.
35. Utsunomiya, A., Miyazaki, Y., Takatsuka, Y., Hanada, S., Uozumi, K., Yashiki, S., Tara, M., Kawano, F., Saburi, Y., Kikuchi, H., Hara, M., Sao, H., Morishima, Y., Kodera, Y., Sonoda, S. & Tomonaga, M. (2001) Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 27, 15-20.
36. Wierecky, J., Muller, M.R., Wirths, S., Halder-Oehler, E., Dorfel, D., Schmidt, S.M., Hantschel, M., Brugger, W., Schroder, S., Horger, M.S., Kanz, L. & Brossart, P. (2006) Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Research, 66, 5910-5918.
37. Wu, L., Adams, M., Carter, T., Chen, R., Muller, G., Stirling, D., Schafer, P. & Bartlett, J.B. (2008) lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Clinical Cancer Research, 14, 4650-4657.